Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements

被引:166
|
作者
Lee, Sang Hoon [1 ]
Bajracharya, Rajiv [1 ]
Min, Jeong Youn [1 ]
Han, Ji-Won [1 ]
Park, Byeong Ju [1 ]
Han, Hyo-Kyung [1 ]
机构
[1] Dongguk Univ Seoul, Coll Pharm, Dongguk Ro 32, Ilsan Donggu 10326, Goyang, South Korea
基金
新加坡国家研究基金会;
关键词
colon; noninvasive drug delivery; inflammatory bowel diseases; colorectal cancer; protein drugs; IMPROVED ORAL BIOAVAILABILITY; IN-VIVO PERFORMANCE; PHARMACOKINETIC EVALUATION; POLYMERIC NANOPARTICLES; THERAPEUTIC-EFFICACY; PEPTIDE LIGAND; PH; COLITIS; MICROSPHERES; FORMULATION;
D O I
10.3390/pharmaceutics12010068
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colon targeted drug delivery systems have gained a great deal of attention as potential carriers for the local treatment of colonic diseases with reduced systemic side effects and also for the enhanced oral delivery of various therapeutics vulnerable to acidic and enzymatic degradation in the upper gastrointestinal tract. In recent years, the global pharmaceutical market for biologics has grown, and increasing demand for a more patient-friendly drug administration system highlights the importance of colonic drug delivery as a noninvasive delivery approach for macromolecules. Colon-targeted drug delivery systems for macromolecules can provide therapeutic benefits including better patient compliance (because they are pain-free and can be self-administered) and lower costs. Therefore, to achieve more efficient colonic drug delivery for local or systemic drug effects, various strategies have been explored including pH-dependent systems, enzyme-triggered systems, receptor-mediated systems, and magnetically-driven systems. In this review, recent advancements in various approaches for designing colon targeted drug delivery systems and their pharmaceutical applications are covered with a particular emphasis on formulation technologies.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Colon Targeted Drug Delivery: Different Approaches
    Jose, S.
    Dhanya, K.
    Cinu, T. A.
    Litty, J.
    Chacko, A. J.
    JOURNAL OF YOUNG PHARMACISTS, 2009, 1 (01) : 13 - 19
  • [2] Gold Nanorods for Drug and Gene Delivery: An Overview of Recent Advancements
    Jahangiri-Manesh, Atieh
    Mousazadeh, Marziyeh
    Taji, Shirinsadat
    Bahmani, Abbas
    Zarepour, Atefeh
    Zarrabi, Ali
    Sharifi, Esmaeel
    Azimzadeh, Mostafa
    PHARMACEUTICS, 2022, 14 (03)
  • [3] Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
    Dasram, Mendhi Henna
    Walker, Roderick B.
    Khamanga, Sandile M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [4] An overview on recent approaches for colonic drug delivery systems
    Deljavan Ghodrati, Aylin
    Comoglu, Tansel
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2024, 29 (06) : 566 - 581
  • [5] Overview of recent advancements in the iontophoretic drug delivery to various tissues and organs
    Helmy, Abdelrahman M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 61
  • [6] Nanotechnology Approaches for Colon Targeted Drug Delivery System: A Review
    Ganguly, Debgopal
    Choudhury, Ananta
    Majumdar, Subhabrota
    JOURNAL OF YOUNG PHARMACISTS, 2023, 15 (02) : 233 - 238
  • [7] Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia, MK
    Jain, SK
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2003, 6 (01): : 33 - 66
  • [8] Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy
    Xu, Jiangsheng
    Shamul, James G.
    Kwizera, Elyahb Allie
    He, Xiaoming
    NANOMATERIALS, 2022, 12 (05)
  • [9] Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications
    Singh, Dilpreet
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2024, 24 (13) : 1480 - 1487
  • [10] Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy
    Bhatia, Rohit
    Sharma, Amit
    Narang, R. K.
    Rawal, Ravindra K.
    CURRENT MOLECULAR PHARMACOLOGY, 2021, 14 (03) : 350 - 366